Terguride, Partial D2 agonist (ab144611)
Key features and details
- Partial D2 agonist. Potent, non-competitive and non-selective 5-HT2 antagonist.
- CAS Number: 37686-84-3
- Purity: > 98%
- Soluble in DMSO and in ethanol
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Terguride, Partial D2 agonist -
Description
Partial D2 agonist. Potent, non-competitive and non-selective 5-HT2 antagonist. -
Purity
> 98% -
CAS Number
37686-84-3 -
Chemical structure
Properties
-
Chemical name
(S)-(+)-N,N-Diethyl-N'([8α]-6-methylergolin-8-yl)urea -
Molecular weight
340.47 -
Molecular formula
C20H28N4O -
PubChem identifier
443951 -
Storage instructions
Store at Room Temperature. Store under desiccating conditions. The product can be stored for up to 12 months. -
Solubility overview
Soluble in DMSO and in ethanol -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Toxic, refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
CCN(CC)C(=O)N[C@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C -
Source
Synthetic
-
Research areas
Images
-
Chemical Structure - Terguride, Partial D2 agonist (ab144611)2D chemical structure image of ab144611, Terguride, Partial D2 agonist
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (2)
ab144611 has been referenced in 2 publications.
- Mann A et al. New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling. Sci Rep 11:8288 (2021). PubMed: 33859231
- Gocht A et al. Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts. Transpl Immunol N/A:N/A (2018). PubMed: 29649585